Flavoxate
- Generic Name
- Flavoxate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H25NO4
- CAS Number
- 15301-69-6
- Unique Ingredient Identifier
- 3E74Y80MEY
- Background
A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist. [PubChem]
- Indication
For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.
- Associated Conditions
- Cystitis, Dysuria, Kidney Stones, Menstrual Distress (Dysmenorrhea), Neurogenic Bladder, Nocturia, Pelvic Floor Dysfunctions, Pelvic Pain, Prostatitis, Suprapubic pain, Urethritis, Urethrotrigonitis, Urinary Incontinence (UI), Urinary Tract Infection, Urinary Urgency, Uterine dyskinesia, Cystalgia, Urethrocystitis
- Associated Therapies
- -
Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-02-27
- Last Posted Date
- 2009-02-05
- Lead Sponsor
- Mahidol University
- Target Recruit Count
- 128
- Registration Number
- NCT00440739
- Locations
- 🇹ðŸ‡
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath